MedTrace Logo

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study

NCT02792478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 238

Last updated 2024-05-13

No results posted yet for this study

Summary

Analysis of freely circulating DNA in liquid biopsies using the BEAMing method

Conditions

  • RAS Wild Type mCRC

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-06
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02792478 on ClinicalTrials.gov